Regencell Bioscience Holdings Ltd (RGC) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $5.94 (-0.34%), Market cap $13.59B, 52-week low–high $10.36 ~ $877.00.
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Financial statements, price targets, institutional (13F) holdings and related news for Regencell Bioscience Holdings Ltd are updated in real time on BlackAll Trade.
Regencell Bioscience Holdings Ltd trades at $5.94 (-0.34%). Real-time quotes and charts are available on BlackAll Trade.
Regencell Bioscience Holdings Ltd has a market cap of about $13.59B.
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the tr